Clinical trial
PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
NCT06486220 is registered in ClinicalTrials.gov with Yun-fei Xia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
- Lead sponsor
- Yun-fei Xia
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 1, 2024
- Completion date
- July 1, 2026
- Enrollment
- 96 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.